NDAORALCAPSULEPriority Review
Approved
Apr 2017
Lifecycle
Peak
Competitive Pressure
8/100
Mechanism of Action
Receptor Tyrosine Kinase Inhibitors
Pharmacologic Class:
Kinase Inhibitor
Loss of Exclusivity
LOE Date
Dec 2, 2030
57 months away
Patent Expiry
Dec 2, 2030